edetic acid has been researched along with sulfasalazine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Banerjee, AK; Peters, TJ | 1 |
| Bjarnason, I; Menzies, I; Smith, T; Somasundaram, S; Teahon, K | 1 |
1 review(s) available for edetic acid and sulfasalazine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for edetic acid and sulfasalazine
| Article | Year |
|---|---|
Experimental non-steroidal anti-inflammatory drug-induced enteropathy in the rat: similarities to inflammatory bowel disease and effect of thromboxane synthetase inhibitors.
Topics: Animals; Cell Membrane Permeability; Chromium Radioisotopes; Disease Models, Animal; Edetic Acid; Ileum; Imidazoles; Indomethacin; Inflammatory Bowel Diseases; Jejunum; Male; Peroxidase; Prednisolone; Rats; Rats, Inbred Strains; Sulfasalazine; Tetracycline; Thromboxane-A Synthase | 1990 |
Assessing the site of increased intestinal permeability in coeliac and inflammatory bowel disease.
Topics: Adult; Biomarkers; Case-Control Studies; Celiac Disease; Chromium Radioisotopes; Cobalt Radioisotopes; Edetic Acid; Female; Humans; Inflammatory Bowel Diseases; Intestinal Absorption; Male; Methylglycosides; Middle Aged; Permeability; Sulfasalazine; Vitamin B 12 | 1996 |